Diabetes Clinical Trials in Portland

Showing 201-220 of 351 trials

A Study of LY2405319 in Participants With Type 2 Diabetes

NCT01869959

The main purpose of this study was to evaluate the safety and tolerability of LY2405319. It was given as a daily injection under the skin to participants with type 2 diabetes mellitus (T2DM) for 28 days. This study determined how long the drug stays in the body and how it affects blood sugar levels. After screening, the study lasted about 2 months for each participant. Participants continued their prestudy regimen of diet and exercise alone or in combination with metformin.

Diabetes Mellitus, Type 2

Eli Lilly and Company47 participantsStarted Apr 2009

Cypress, California, United States • Tustin, California, United States • DeLand, Florida, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

NCT01128894

This open-label study examines the efficacy and safety of albiglutide as compared with liraglutide in subjects with type 2 diabetes.

Diabetes Mellitus, Type 2

GlaxoSmithKline841 participantsStarted May 2010

Birmingham, Alabama, United States • Chandler, Arizona, United States • Gilbert, Arizona, United States +170 more locations

A Study of LY2405319 in Participants With Type 2 Diabetes

A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.

Diabetes Trials in Other Cities

Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes

The Effect of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin on Glycaemic Control in Subjects With Type 2 Diabetes Mellitus

Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Trial Comparing the Efficacy, Patient-reported Outcomes and Safety of Insulin Degludec 200 U/mL vs Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Requiring High-dose Insulin

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes

Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Metformin in Subjects With Type 2 Diabetes

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Evaluation of an Investigational Blood Glucose Monitoring System

Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes

Study In People With Type 2 Diabetes

Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes

Other Conditions in Portland